These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 28258219

  • 1. Resolving the cofactor-binding site in the proline biosynthetic enzyme human pyrroline-5-carboxylate reductase 1.
    Christensen EM, Patel SM, Korasick DA, Campbell AC, Krause KL, Becker DF, Tanner JJ.
    J Biol Chem; 2017 Apr 28; 292(17):7233-7243. PubMed ID: 28258219
    [Abstract] [Full Text] [Related]

  • 2. Screening a knowledge-based library of low molecular weight compounds against the proline biosynthetic enzyme 1-pyrroline-5-carboxylate 1 (PYCR1).
    Meeks KR, Bogner AN, Tanner JJ.
    Protein Sci; 2024 Jul 28; 33(7):e5072. PubMed ID: 39133178
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Novel Fragment Inhibitors of PYCR1 from Docking-Guided X-ray Crystallography.
    Meeks KR, Ji J, Protopopov MV, Tarkhanova OO, Moroz YS, Tanner JJ.
    J Chem Inf Model; 2024 Mar 11; 64(5):1704-1718. PubMed ID: 38411104
    [Abstract] [Full Text] [Related]

  • 6. Functional Impact of a Cancer-Related Variant in Human Δ1-Pyrroline-5-Carboxylate Reductase 1.
    Daudu OI, Meeks KR, Zhang L, Seravalli J, Tanner JJ, Becker DF.
    ACS Omega; 2023 Jan 24; 8(3):3509-3519. PubMed ID: 36713721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In silico screening, molecular docking, and molecular dynamics studies of SNP-derived human P5CR mutants.
    Sang P, Hu W, Ye YJ, Li LH, Zhang C, Xie YH, Meng ZH.
    J Biomol Struct Dyn; 2017 Aug 24; 35(11):2441-2453. PubMed ID: 27677826
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Structure, biochemistry, and gene expression patterns of the proline biosynthetic enzyme pyrroline-5-carboxylate reductase (PYCR), an emerging cancer therapy target.
    Bogner AN, Stiers KM, Tanner JJ.
    Amino Acids; 2021 Dec 24; 53(12):1817-1834. PubMed ID: 34003320
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Genetic analysis of Pycr1 and Pycr2 in mice.
    Stum MG, Tadenev ALD, Seburn KL, Miers KE, Poon PP, McMaster CR, Robinson C, Kane C, Silva KA, Cliften PF, Sundberg JP, Reinholdt LG, John SWM, Burgess RW.
    Genetics; 2021 May 17; 218(1):. PubMed ID: 33734376
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. SIRT3 regulates cancer cell proliferation through deacetylation of PYCR1 in proline metabolism.
    Chen S, Yang X, Yu M, Wang Z, Liu B, Liu M, Liu L, Ren M, Qi H, Zou J, Vucenik I, Zhu WG, Luo J.
    Neoplasia; 2019 Jul 17; 21(7):665-675. PubMed ID: 31108370
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. High-resolution studies of hydride transfer in the ferredoxin:NADP+ reductase superfamily.
    Kean KM, Carpenter RA, Pandini V, Zanetti G, Hall AR, Faber R, Aliverti A, Karplus PA.
    FEBS J; 2017 Oct 17; 284(19):3302-3319. PubMed ID: 28783258
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.